Advertisement
Screener

Zosano Pharma Corp Net Income

Zosano Pharma Corp Net Income

Zosano Pharma Corp reported Net Income of -$33.41 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.

Discontinued › Income Statement › Net Income

us-gaap:NetIncomeLoss · last filed 2022-05-13

  • Zosano Pharma Corp net income (loss) attributable to parent for the quarter ending 2022-03-31 was -$33.41M.
  • Zosano Pharma Corp net income (loss) attributable to parent for the quarter ending 2021-12-31 was -$6.97M.
  • Zosano Pharma Corp net income (loss) attributable to parent for the quarter ending 2021-09-30 was -$8.67M.
  • Zosano Pharma Corp net income (loss) attributable to parent for the quarter ending 2021-06-30 was -$6.14M.
  • Zosano Pharma Corp net income (loss) attributable to parent for fiscal 2021 was -$29.93M.
  • Zosano Pharma Corp net income (loss) attributable to parent for fiscal 2020 was -$33.37M.
  • Zosano Pharma Corp net income (loss) attributable to parent for fiscal 2019 was -$37.59M.
  • Zosano Pharma Corp net income (loss) attributable to parent for fiscal 2018 was -$35.36M.
Period endNet Income (Loss) Attributable to Parent 3 monthNet Income (Loss) Attributable to Parent 6 monthNet Income (Loss) Attributable to Parent 9 monthNet Income (Loss) Attributable to Parent 12 month
2022-03-31-$33.41M
10-Q · filed 2022-05-13
-$40.38M
derived: sum of 2 quarters · filed 2022-05-13
-$49.05M
derived: sum of 3 quarters · filed 2022-05-13
-$55.19M
derived: sum of 4 quarters · filed 2022-05-13
2021-12-31-$6.97M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$15.64M
derived: sum of 2 quarters · filed 2022-03-17
-$21.78M
derived: sum of 3 quarters · filed 2022-03-17
-$29.93M
10-K · filed 2022-03-17
2021-09-30-$8.67M
10-Q · filed 2021-11-10
-$14.81M
derived: sum of 2 quarters · filed 2021-11-10
-$22.95M
10-Q · filed 2021-11-10
-$31.05M
derived: sum of 4 quarters · filed 2022-05-13
2021-06-30-$6.14M
10-Q · filed 2021-11-10
-$14.29M
10-Q · filed 2021-08-10
-$22.38M
derived: sum of 3 quarters · filed 2022-05-13
-$31.07M
derived: sum of 4 quarters · filed 2022-05-13
2021-03-31-$8.14M
10-Q · filed 2022-05-13
-$16.24M
derived: sum of 2 quarters · filed 2022-05-13
-$24.93M
derived: sum of 3 quarters · filed 2022-05-13
-$32.82M
derived: sum of 4 quarters · filed 2022-05-13
2020-12-31-$8.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17
-$16.79M
derived: sum of 2 quarters · filed 2022-03-17
-$24.68M
derived: sum of 3 quarters · filed 2022-03-17
-$33.37M
10-K · filed 2022-03-17
2020-09-30-$8.69M
10-Q · filed 2021-11-10
-$16.58M
derived: sum of 2 quarters · filed 2021-11-10
-$25.27M
10-Q · filed 2021-11-10
-$34.21M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30-$7.89M
10-Q · filed 2021-11-10
-$16.58M
10-Q · filed 2021-08-10
-$25.52M
derived: sum of 3 quarters · filed 2021-11-10
-$35.39M
derived: sum of 4 quarters · filed 2021-11-10
2020-03-31-$8.69M
10-Q · filed 2021-11-10
-$17.63M
derived: sum of 2 quarters · filed 2021-11-10
-$27.49M
derived: sum of 3 quarters · filed 2021-11-10
-$36.85M
derived: sum of 4 quarters · filed 2021-11-10
2019-12-31-$8.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
-$18.80M
derived: sum of 2 quarters · filed 2021-03-11
-$28.16M
derived: sum of 3 quarters · filed 2021-03-11
-$37.59M
10-K · filed 2021-03-11
2019-09-30-$9.86M
10-Q · filed 2020-11-13
-$19.22M
derived: sum of 2 quarters · filed 2020-11-13
-$28.65M
10-Q · filed 2020-11-13
-$38.80M
derived: sum of 4 quarters · filed 2020-11-13
2019-06-30-$9.36M
10-Q · filed 2020-11-13
-$18.79M
10-Q · filed 2020-08-06
-$28.93M
derived: sum of 3 quarters · filed 2020-11-13
-$37.10M
derived: sum of 4 quarters · filed 2020-11-13
2019-03-31-$9.43M
10-Q · filed 2020-11-13
-$19.57M
derived: sum of 2 quarters · filed 2020-11-13
-$27.74M
derived: sum of 3 quarters · filed 2020-11-13
-$36.58M
derived: sum of 4 quarters · filed 2020-11-13
2018-12-31-$10.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$18.32M
derived: sum of 2 quarters · filed 2020-03-13
-$27.15M
derived: sum of 3 quarters · filed 2020-03-13
-$35.36M
10-K · filed 2020-03-13
2018-09-30-$8.17M
10-Q · filed 2019-11-14
-$17.00M
derived: sum of 2 quarters · filed 2019-11-14
-$25.21M
10-Q · filed 2019-11-14
-$32.70M
derived: sum of 4 quarters · filed 2019-11-14
2018-06-30-$8.84M
10-Q · filed 2019-11-14
-$17.04M
10-Q · filed 2019-08-14
-$24.53M
derived: sum of 3 quarters · filed 2019-11-14
-$32.40M
derived: sum of 4 quarters · filed 2019-11-14
2018-03-31-$8.21M
10-Q · filed 2019-11-14
-$15.70M
derived: sum of 2 quarters · filed 2019-11-14
-$23.57M
derived: sum of 3 quarters · filed 2019-11-14
-$30.31M
derived: sum of 4 quarters · filed 2019-11-14
2017-12-31-$7.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25
-$15.36M
derived: sum of 2 quarters · filed 2019-03-25
-$22.11M
derived: sum of 3 quarters · filed 2019-03-25
-$29.11M
10-K · filed 2019-03-25
2017-09-30-$7.87M
10-Q · filed 2018-11-15
-$14.62M
derived: sum of 2 quarters · filed 2018-11-15
-$21.62M
10-Q · filed 2018-11-15
-$29.36M
derived: sum of 4 quarters · filed 2018-11-15
2017-06-30-$6.75M
10-Q · filed 2017-08-10
-$13.74M
10-Q · filed 2018-08-09
-$21.49M
derived: sum of 3 quarters · filed 2018-08-09
-$28.94M
derived: sum of 4 quarters · filed 2018-08-09
2017-03-31-$7.00M
10-Q · filed 2018-05-15
-$14.75M
derived: sum of 2 quarters · filed 2018-05-15
-$22.19M
derived: sum of 3 quarters · filed 2018-05-15
-$28.71M
derived: sum of 4 quarters · filed 2018-05-15
2016-12-31-$7.75M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
-$15.20M
derived: sum of 2 quarters · filed 2018-03-12
-$21.72M
derived: sum of 3 quarters · filed 2018-03-12
-$29.83M
10-K · filed 2018-03-12
2016-09-30-$7.45M
10-Q · filed 2017-11-09
-$13.97M
derived: sum of 2 quarters · filed 2017-11-09
-$22.08M
10-Q · filed 2017-11-09
-$29.73M
derived: sum of 4 quarters · filed 2017-11-09
2016-06-30-$6.52M
10-Q · filed 2017-08-10
-$14.63M
10-Q · filed 2017-08-10
-$22.28M
derived: sum of 3 quarters · filed 2017-08-10
-$30.90M
derived: sum of 4 quarters · filed 2017-08-10
2016-03-31-$8.12M
10-Q · filed 2017-05-09
-$15.76M
derived: sum of 2 quarters · filed 2017-05-09
-$24.38M
derived: sum of 3 quarters · filed 2017-05-09
-$31.96M
derived: sum of 4 quarters · filed 2017-05-09
2015-12-31-$7.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
-$16.27M
derived: sum of 2 quarters · filed 2017-03-01
-$23.84M
derived: sum of 3 quarters · filed 2017-03-01
-$28.43M
10-K · filed 2017-03-01
2015-09-30-$8.62M
10-Q · filed 2016-11-09
-$16.20M
derived: sum of 2 quarters · filed 2016-11-09
-$20.78M
10-Q · filed 2016-11-09
-$25.06M
derived: sum of 4 quarters · filed 2016-11-09
2015-06-30-$7.58M
10-Q · filed 2016-08-10
-$12.16M
10-Q · filed 2016-08-10
-$16.44M
derived: sum of 3 quarters · filed 2016-08-10
-$20.12M
derived: sum of 4 quarters · filed 2016-08-10
2015-03-31-$4.58M
10-Q · filed 2016-05-12
-$8.86M
derived: sum of 2 quarters · filed 2016-05-12
-$12.54M
derived: sum of 3 quarters · filed 2016-05-12
-$16.45M
derived: sum of 4 quarters · filed 2016-05-12
2014-12-31-$4.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29
-$7.96M
derived: sum of 2 quarters · filed 2016-03-29
-$11.87M
derived: sum of 3 quarters · filed 2016-03-29
-$14.24M
10-K · filed 2016-03-29
2014-09-30-$3.68M
10-Q · filed 2015-11-10
-$7.59M
derived: sum of 2 quarters · filed 2015-11-10
-$9.96M
10-Q · filed 2015-11-10
2014-06-30-$3.91M
10-Q · filed 2015-08-13
-$6.28M
10-Q · filed 2015-08-13
2014-03-31-$2.37M
10-Q · filed 2015-05-12